The somatic autosomal mutation matrix in cancer genomes
- PMID: 26001532
- PMCID: PMC4495249
- DOI: 10.1007/s00439-015-1566-1
The somatic autosomal mutation matrix in cancer genomes
Erratum in
-
Erratum to: The somatic autosomal mutation matrix in cancer genomes.Hum Genet. 2015 Aug;134(8):865-7. doi: 10.1007/s00439-015-1576-z. Hum Genet. 2015. PMID: 26071096 Free PMC article. No abstract available.
Abstract
DNA damage in somatic cells originates from both environmental and endogenous sources, giving rise to mutations through multiple mechanisms. When these mutations affect the function of critical genes, cancer may ensue. Although identifying genomic subsets of mutated genes may inform therapeutic options, a systematic survey of tumor mutational spectra is required to improve our understanding of the underlying mechanisms of mutagenesis involved in cancer etiology. Recent studies have presented genome-wide sets of somatic mutations as a 96-element vector, a procedure that only captures the immediate neighbors of the mutated nucleotide. Herein, we present a 32 × 12 mutation matrix that captures the nucleotide pattern two nucleotides upstream and downstream of the mutation. A somatic autosomal mutation matrix (SAMM) was constructed from tumor-specific mutations derived from each of 909 individual cancer genomes harboring a total of 10,681,843 single-base substitutions. In addition, mechanistic template mutation matrices (MTMMs) representing oxidative DNA damage, ultraviolet-induced DNA damage, (5m)CpG deamination, and APOBEC-mediated cytosine mutation, are presented. MTMMs were mapped to the individual tumor SAMMs to determine the maximum contribution of each mutational mechanism to the overall mutation pattern. A Manhattan distance across all SAMM elements between any two tumor genomes was used to determine their relative distance. Employing this metric, 89.5% of all tumor genomes were found to have a nearest neighbor from the same tissue of origin. When a distance-dependent 6-nearest neighbor classifier was used, 10.4% of the SAMMs had an Undetermined tissue of origin, and 92.2% of the remaining SAMMs were assigned to the correct tissue of origin. [corrected]. Thus, although tumors from different tissues may have similar mutation patterns, their SAMMs often display signatures that are characteristic of specific tissues.
Similar articles
-
Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.PLoS Genet. 2018 Nov 9;14(11):e1007779. doi: 10.1371/journal.pgen.1007779. eCollection 2018 Nov. PLoS Genet. 2018. PMID: 30412573 Free PMC article.
-
Patterns and processes of somatic mutations in nine major cancers.BMC Med Genomics. 2014 Feb 19;7:11. doi: 10.1186/1755-8794-7-11. BMC Med Genomics. 2014. PMID: 24552141 Free PMC article.
-
Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.DNA Repair (Amst). 2018 Nov;71:6-11. doi: 10.1016/j.dnarep.2018.08.003. Epub 2018 Aug 24. DNA Repair (Amst). 2018. PMID: 30236628 Free PMC article. Review.
-
Mechanisms underlying mutational signatures in human cancers.Nat Rev Genet. 2014 Sep;15(9):585-98. doi: 10.1038/nrg3729. Epub 2014 Jul 1. Nat Rev Genet. 2014. PMID: 24981601 Free PMC article. Review.
-
Somatic mutation load and spectra: A record of DNA damage and repair in healthy human cells.Environ Mol Mutagen. 2018 Oct;59(8):672-686. doi: 10.1002/em.22215. Epub 2018 Aug 27. Environ Mol Mutagen. 2018. PMID: 30152078 Free PMC article. Review.
Cited by
-
AVIA 3.0: interactive portal for genomic variant and sample level analysis.Bioinformatics. 2021 Aug 25;37(16):2467-2469. doi: 10.1093/bioinformatics/btaa994. Bioinformatics. 2021. PMID: 33289511 Free PMC article.
-
Structural underpinnings of mutation rate variations in the human genome.Nucleic Acids Res. 2023 Aug 11;51(14):7184-7197. doi: 10.1093/nar/gkad551. Nucleic Acids Res. 2023. PMID: 37395403 Free PMC article.
-
Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction.Prog Biophys Mol Biol. 2019 Oct;147:47-61. doi: 10.1016/j.pbiomolbio.2019.03.004. Epub 2019 Mar 14. Prog Biophys Mol Biol. 2019. PMID: 30880007 Free PMC article.
-
Mutational signatures and mutable motifs in cancer genomes.Brief Bioinform. 2018 Nov 27;19(6):1085-1101. doi: 10.1093/bib/bbx049. Brief Bioinform. 2018. PMID: 28498882 Free PMC article. Review.
-
Postmastectomy Radiation Therapy: Are We Ready to Individualize Radiation?Int J Breast Cancer. 2018 Mar 1;2018:1402824. doi: 10.1155/2018/1402824. eCollection 2018. Int J Breast Cancer. 2018. PMID: 29686906 Free PMC article. Review.
References
-
- Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein BT, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154–1157. doi: 10.1126/science.1206923. - DOI - PMC - PubMed
-
- Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinsk M, Jager N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdes-Mas R, van Buuren MM, van ‘t Veer L, Vincent-Salomon A, Waddell N, Yates LR, Australian Pancreatic Cancer Genome I, Consortium IBC, Consortium IM-S, PedBrain I, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR (2013a) Signatures of mutational processes in human cancer. Nature 500: 415–421. doi: 10.1038/nature12477 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources